FOLD — Amicus Therapeutics Share News
0.000.00%
Last trade - 00:00- $4.55bn
- $4.65bn
- $634.21m
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Amicus Q4 revenue beats estimates
U.S. RESEARCH ROUNDUP- Cencora, Crocs, Teledyne Technologies
U.S. RESEARCH ROUNDUP-Expedia Group, Hasbro, Palisade Bio
U.S. RESEARCH ROUNDUP-Comerica, Heico, Walmart
Australia's Dimerix hits 7-month high on $4.8 billion sale
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Brief: Biomarin To Acquire Amicus Therapeutics For $4.8 Billion
Amicus rises after BioMarin's $4.8 billion buyout deal
BioMarin to acquire Amicus Therapeutics for $4.8 billion (updated)
NASDAQ RESUMED AT 08:05 AM
BioMarin to acquire Amicus Therapeutics for $4.8 Billion
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:40 AM
Amicus Therapeutics Q3 revenue growth more than expected
U.S. STOCKS ON THE MOVE- Jefferies Financial, Amer Sports
Needham ups Amicus Therapeutics to 'buy'